Atıf Formatları
Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. GÜMÜŞLÜ, "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment," XXII World Allergy Congress (WAC) , Cancun, Mexico, pp.2125, 2011

GÜMÜŞLÜ, S. 2011. Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment. XXII World Allergy Congress (WAC) , (Cancun, Mexico), 2125.

GÜMÜŞLÜ, S., (2011). Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment . XXII World Allergy Congress (WAC) (pp.2125). Cancun, Mexico

GÜMÜŞLÜ, SAADET. "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment," XXII World Allergy Congress (WAC), Cancun, Mexico, 2011

GÜMÜŞLÜ, SAADET. "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment." XXII World Allergy Congress (WAC) , Cancun, Mexico, pp.2125, 2011

GÜMÜŞLÜ, S. (2011) . "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment." XXII World Allergy Congress (WAC) , Cancun, Mexico, p.2125.

@conferencepaper{conferencepaper, author={SAADET GÜMÜŞLÜ}, title={Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment}, congress name={XXII World Allergy Congress (WAC)}, city={Cancun}, country={Mexico}, year={2011}, pages={2125} }